Showing results (111-120 of 169) with videos related to
Sort By:
Pageof 17
Journal of Medical Microbiology|January 19, 2008
Mycobacterium tuberculosis strains disrupted in mce3 and mce4 operons are attenuated in miceRyan H Senaratne, Ben Sidders, Patricia Sequeira, et al.Clinical Chemistry|May 25, 2002
Multicenter evaluation of an automated assay for troponin IDenise Uettwiller-Geiger, Alan H B Wu, Fred S Apple, et al.Breast Cancer Research and Treatment|June 29, 2014
Adverse prognostic and predictive significance of low DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in early-stage breast cancersTarek Abdel-Fatah, Arvind Arora, Devika Agarwal, et al.Breast Cancer Research and Treatment|February 22, 2014
Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assayFabrício F T Barros, Tarek M A Abdel-Fatah, Paul Moseley, et al.Breast Cancer Research and Treatment|April 8, 2014
HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancerAndrew R Green, Fabrício F T Barros, Tarek M A Abdel-Fatah, et al.NPJ Digital Medicine|April 4, 2026
Comparison of AI-generated radiology impressions: a multi-stakeholder evaluationSharang Phadke, Nivedita Suresh, Zachary Allen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2011
Randomized, placebo-controlled, double-blind, phase II study of axitinib plus docetaxel versus docetaxel plus placebo in patients with metastatic breast cancerHope S Rugo, Alison T Stopeck, Anil A Joy, et al.Oncotarget|July 16, 2014
Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic eraChristina Perry, Devika Agarwal, Tarek M A Abdel-Fatah, et al.Molecular Oncology|January 28, 2014
DNA polymerase β deficiency is linked to aggressive breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohortsTarek M A Abdel-Fatah, Roslin Russell, Devika Agarwal, et al.American Journal of Clinical Oncology|June 3, 2009
Phase 2 study of single-agent IV vinflunine as third-line treatment of metastatic breast cancer after failure of anthracycline-/taxane-based chemotherapyPierre Fumoleau, Hernan Cortés-Funes, Amina B Taleb, et al.Pageof 17